Diagnostic accuracy and safety of percutaneous bone biopsy in histopathological diagnosis of metastatic bone lesions with known or unknown origin
IMAGING, cilt.13, sa.2, ss.124-129, 2021 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 13 Sayı: 2
- Basım Tarihi: 2021
- Doi Numarası: 10.1556/1647.2021.00026
- Dergi Adı: IMAGING
- Derginin Tarandığı İndeksler: Scopus, Academic Search Premier
- Sayfa Sayıları: ss.124-129
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Metastasis of a primary cancer is an important determining factor in morbidity and mortality. A new lesion in the bone may be more likely a metastasis than a primary bone cancer [1, 2, 3]. On the other hand, although a new bone lesion may be a metastasis of an unknown primary cancer, a new lesion detected during follow up of a cancer may not be associated with the known primary tumor. Thus, to plan a personalised treatment, diagnosis of a newly detected bone lesion is crucial. Bone metastasis may be present in most of the cancers; most frequently in lung, breast and prostate cancers [1, 2, 3]. Pain and pathological fractures are the main symptomes of bone metastasis. Needle core biopsy or surgical biopsy is recommended for histological evaluation. As a less invasive diagnostic tool, image-guided percutaneous biopsy may be preferred over surgical biopsy [4]. In this study, we aimed to share our results of image guided percutaneous bone biopsies and histopathological diagnosis of metastatic bone masses in patients with known and unknown primary cancers.